PyInvesting

Market research

3386.TSE Cosmo Bio Company,Limited

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
7B
P/E ratio
19.53
Analyst target
Not available
Dividend yield
4.0%
Beta
0.19

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Cosmo Bio Company,Limited is currently in a long term uptrend where the price is trading 0.2% above its 200 day moving average.

From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.

Cosmo Bio Company,Limited's total revenue rose by 13.6% to $2B since the same quarter in the previous year.

Its net income has increased by 550.0% to $99M since the same quarter in the previous year.

Based on the above factors, Cosmo Bio Company,Limited gets an overall score of 4/5.